Nick Haining
Harvard University
H-index: 54
North America-United States
Top articles of Nick Haining
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Modulating dsRNA editing, sensing, and metabolism to increase tumor immunity and improve the efficacy of cancer immunotherapy and/or modulators of intratumoral interferon | 2024/1/16 | ||
X-CHIME enables combinatorial, inducible, lineage-specific and sequential knockout of genes in the immune system | Nature Immunology | Martin W LaFleur Ashlyn M Lemmen Ivy SL Streeter Thao H Nguyen Lauren E Milling | 2024/1 |
Stepwise activities of mSWI/SNF family chromatin remodeling complexes direct T cell activation and exhaustion | Molecular cell | Elena Battistello Kimberlee A Hixon Dawn E Comstock Clayton K Collings Xufeng Chen | 2023/4/20 |
Overcoming resistance to immunotherapy due to loss of antigen presentation | Cancer Research | Brian C Miller Yacine Choutri Rose Al Abosy Amy Huang Emily K Cox | 2023/4/4 |
Targeting mammalian SWI/SNF chromatin remodeling complexes to improve T cell-based cancer immunotherapies | Cancer Research | Elena Battistello Kimberlee Hixon Dawn E Comstock Clayton K Collings Xufeng Chen | 2023/4/4 |
Multiplexed shRNA cassettes targeting orthogonal pathways (FAS/PTPN2/TGFBR) enhance the potency of integrated circuit T cells (ICTs) in multiple solid tumor models | Cancer Research | Thomas J Gardner Adam Litterman Brenal K Singh Luisa Silva Mukund Hari | 2023/4/4 |
Modulating biomarkers to increase tumor immunity and improve the efficacy of cancer immunotherapy | 2020/9/24 | ||
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer | Nature Immunology | Juan Dubrot Peter P Du Sarah Kate Lane-Reticker Emily A Kessler Audrey J Muscato | 2022/10 |
Batf-mediated epigenetic control of effector CD8+ T cell differentiation | Science Immunology | Hsiao-Wei Tsao James Kaminski Makoto Kurachi R. Anthony Barnitz Michael A. DiIorio | 2022/3/17 |
Multiplexed shRNAs targeting FAS and PTPN2 enhance CAR T persistence and anti-tumor efficacy | Cancer Research | John Gagnon Adam J Litterman Jason A Hall Dina Polyak Stanley Zhou | 2022/6/15 |
Improved vector systems for cas protein and sgrna delivery, and uses therefor | 2022/1/20 | ||
Retention of epigenetic and transcriptional memory among reprogrammed T cells (T-iPSCs) imparts selective advantage for T cell re-differentiation. | The Journal of Immunology | Robin L Williams Alyssa Morrow Jeremy Allred Jakub Tolar W Nicholas Haining | 2022/5/1 |
PI3K activation allows immune evasion by promoting an inhibitory myeloid tumor microenvironment | Journal for ImmunoTherapy of Cancer | Natalie B Collins Rose Al Abosy Brian C Miller Kevin Bi Qihong Zhao | 2022 |
Modulating ptpn2 to increase immune responses and perturbing gene expression in hematopoietic stem cell lineages | 2022/3/17 | ||
When cancer cells become the enablers of an antitumor immune response | Cancer Discovery | Antoni Ribas W Nicholas Haining Ton NM Schumacher | 2022/10/5 |
Modulating biomarkers such as spp to increase tumor immunity and improve the efficacy of cancer immunotherapy | 2022/2/24 | ||
T-cell exhaustion state-specific gene expression regulators and uses thereof | 2021/10/7 | ||
Epigenetic features of HIV-induced T-cell exhaustion persist despite early antiretroviral therapy | Frontiers in immunology | Genevieve E Martin Debattama R Sen Matthew Pace Nicola Robinson Jodi Meyerowitz | 2021/6/4 |
In vivo screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinoma | Immunity | Juan Dubrot Sarah Kate Lane-Reticker Emily A Kessler Austin Ayer Gargi Mishra | 2021/3/9 |
Epigenetic scars of CD8+ T cell exhaustion persist after cure of chronic infection in humans | Nature immunology | Kathleen B Yates Pierre Tonnerre Genevieve E Martin Ulrike Gerdemann Rose Al Abosy | 2021/8 |
